Table of Content

Executive Summary
1. Global Cancer Diagnostics Market Snapshot, 2025 and 2032
2. Market Opportunity Assessment, 2025 - 2032, US$ Bn
3. Key Market Trends
4. Future Market Projections
5. Premium Market Insights
6. Industry Developments and Key Market Events
7. PMR Analysis and Recommendations
Market Overview
1. Market Scope and Definition
2. Market Dynamics
  1. Drivers
  2. Restraints
  3. Opportunity
  4. Challenges
  5. Key Trends
3. COVID-19 Impact Analysis
4. Forecast Factors - Relevance and Impact
Value Added Insights
1. Value Chain Analysis
2. Diagnostic Test Adoption / Usage Analysis
3. Prevalence & Incidence of Cancer
4. Government Initiatives & Funding in Cancer Diagnostics
5. Key Market Players
6. Regulatory Landscape
7. PESTLE Analysis
8. Porter’s Five Force Analysis
9. Consumer Behavior Analysis
Global Cancer Diagnostics Market Outlook
1. Key Highlights
  1. Market Size (US$ Bn) and Y-o-Y Growth
  2. Absolute $ Opportunity
2. Market Size (US$ Bn) Analysis and Forecast
  1. Historical Market Size (US$ Bn) Analysis, 2019-2023
  2. Current Market Size (US$ Bn) Analysis and Forecast, 2024-2032
3. Global Cancer Diagnostics Market Outlook Diagnostic Test
  1. Historical Market Size (US$ Bn) Analysis, By Diagnostic Test, 2019-2023
  2. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
    1. Biomarker Test
      1. Prostate-Specific Antigen (PSA)
      2. Circulating Tumor Cells (CTC)
      3. Alpha-Fetoprotein (AFP)
      4. Cancer Antigen 125 (CA-125)
      5. HER2
      6. Other
    2. Imaging Technology
      1. Magnetic Resonance Imaging (MRI)
      2. Computed Tomography (CT)
      3. Positron Emission Tomography (PET)
      4. Mammography
      5. Others
    3. Endoscopy
    4. Colonoscopy
    5. Biopsy
    6. Others
  3. Market Attractiveness Analysis: Diagnostic Test
4. Global Cancer Diagnostics Market Outlook Form
  1. Historical Market Size (US$ Bn) Analysis, By Form, 2019-2023
  2. Current Market Size (US$ Bn) Analysis and Forecast, By Form, 2024-2032
    1. Isolates
    2. Concentrates
    3. Hydrolysates
  3. Market Attractiveness Analysis: Form
5. Global Cancer Diagnostics Market Outlook Application
  1. Historical Market Size (US$ Bn) Analysis, By Application, 2019-2023
  2. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
    1. Lung Cancer
    2. Breast Cancer
    3. Prostate Cancer
    4. Colorectal Cancer
    5. Melanoma Cancer
    6. Blood Cancer
    7. Ovarian Cancer
    8. Other
  3. Market Attractiveness Analysis: Application
6. Global Cancer Diagnostics Market Outlook End-use
  1. Historical Market Size (US$ Bn) Analysis, By End-use, 2019-2023
  2. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
    1. Hospitals
    2. Diagnostic Laboratories
    3. Cancer Research Institutes
    4. Ambulatory Surgical Centers
  3. Market Attractiveness Analysis: End-use
Global Cancer Diagnostics Market Outlook Region
1. Historical Market Size (US$ Bn) Analysis, By Region, 2019-2023
2. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2024-2032
  1. North America
  2. Latin America
  3. Europe
  4. East Asia
  5. South Asia and Oceania
  6. Middle East & Africa
3. Market Attractiveness Analysis: Region
North America Cancer Diagnostics Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  1. By Country
  2. By Diagnostic Test
  3. By Application
  4. By End-use
2. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2032
  1. U.S.
  2. Canada
3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
  1. Biomarker Test
    1. Prostate-Specific Antigen (PSA)
    2. Circulating Tumor Cells (CTC)
    3. Alpha-Fetoprotein (AFP)
    4. Cancer Antigen 125 (CA-125)
    5. HER2
    6. Other
  2. Imaging Technology
    1. Magnetic Resonance Imaging (MRI)
    2. Computed Tomography (CT)
    3. Positron Emission Tomography (PET)
    4. Mammography
    5. Others
  3. Endoscopy
  4. Colonoscopy
  5. Biopsy
  6. Others
4. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Blood Cancer
  7. Ovarian Cancer
  8. Other
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
  1. Hospitals
  2. Diagnostic Laboratories
  3. Cancer Research Institutes
  4. Ambulatory Surgical Centers
6. Market Attractiveness Analysis
Europe Cancer Diagnostics Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  1. By Country
  2. By Diagnostic Test
  3. By Form
  4. By Application
  5. By End-use
2. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2032
  1. Germany
  2. France
  3. U.K.
  4. Italy
  5. Spain
  6. Russia
  7. Rest of Europe
3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
  1. Biomarker Test
    1. Prostate-Specific Antigen (PSA)
    2. Circulating Tumor Cells (CTC)
    3. Alpha-Fetoprotein (AFP)
    4. Cancer Antigen 125 (CA-125)
    5. HER2
    6. Other
  2. Imaging Technology
    1. Magnetic Resonance Imaging (MRI)
    2. Computed Tomography (CT)
    3. Positron Emission Tomography (PET)
    4. Mammography
    5. Others
  3. Endoscopy
  4. Colonoscopy
  5. Biopsy
  6. Others
4. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Blood Cancer
  7. Ovarian Cancer
  8. Other
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
  1. Hospitals
  2. Diagnostic Laboratories
  3. Cancer Research Institutes
  4. Ambulatory Surgical Centers
6. Market Attractiveness Analysis
East Asia Cancer Diagnostics Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  1. By Country
  2. By Diagnostic Test
  3. By Application
  4. By End-use
2. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2032
  1. China
  2. Japan
  3. South Korea
3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
  1. Biomarker Test
    1. Prostate-Specific Antigen (PSA)
    2. Circulating Tumor Cells (CTC)
    3. Alpha-Fetoprotein (AFP)
    4. Cancer Antigen 125 (CA-125)
    5. HER2
    6. Other
  2. Imaging Technology
    1. Magnetic Resonance Imaging (MRI)
    2. Computed Tomography (CT)
    3. Positron Emission Tomography (PET)
    4. Mammography
    5. Others
  3. Endoscopy
  4. Colonoscopy
  5. Biopsy
  6. Others
4. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Blood Cancer
  7. Ovarian Cancer
  8. Other
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
  1. Hospitals
  2. Diagnostic Laboratories
  3. Cancer Research Institutes
  4. Ambulatory Surgical Centers
6. Market Attractiveness Analysis
South Asia & Oceania Cancer Diagnostics Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  1. By Country
  2. By Diagnostic Test
  3. By Application
  4. By End-use
2. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2032
  1. India
  2. Indonesia
  3. Thailand
  4. Singapore
  5. ANZ
  6. Rest of South Asia & Oceania
3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
  1. Biomarker Test
    1. Prostate-Specific Antigen (PSA)
    2. Circulating Tumor Cells (CTC)
    3. Alpha-Fetoprotein (AFP)
    4. Cancer Antigen 125 (CA-125)
    5. HER2
    6. Other
  2. Imaging Technology
    1. Magnetic Resonance Imaging (MRI)
    2. Computed Tomography (CT)
    3. Positron Emission Tomography (PET)
    4. Mammography
    5. Others
  3. Endoscopy
  4. Colonoscopy
  5. Biopsy
  6. Others
4. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Blood Cancer
  7. Ovarian Cancer
  8. Other
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
  1. Hospitals
  2. Diagnostic Laboratories
  3. Cancer Research Institutes
  4. Ambulatory Surgical Centers
6. Market Attractiveness Analysis
Latin America Cancer Diagnostics Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  1. By Country
  2. By Diagnostic Test
  3. By Application
  4. By End-use
2. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2032
  1. Brazil
  2. Mexico
  3. Rest of Latin America
3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
  1. Biomarker Test
    1. Prostate-Specific Antigen (PSA)
    2. Circulating Tumor Cells (CTC)
    3. Alpha-Fetoprotein (AFP)
    4. Cancer Antigen 125 (CA-125)
    5. HER2
    6. Other
  2. Imaging Technology
    1. Magnetic Resonance Imaging (MRI)
    2. Computed Tomography (CT)
    3. Positron Emission Tomography (PET)
    4. Mammography
    5. Others
  3. Endoscopy
  4. Colonoscopy
  5. Biopsy
  6. Others
4. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Blood Cancer
  7. Ovarian Cancer
  8. Other
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
  1. Hospitals
  2. Diagnostic Laboratories
  3. Cancer Research Institutes
  4. Ambulatory Surgical Centers
6. Market Attractiveness Analysis
Middle East & Africa Cancer Diagnostics Market Outlook
1. Historical Market Size (US$ Bn) Analysis, By Market, 2019-2023
  1. By Country
  2. By Diagnostic Test
  3. By Application
  4. By End-use
2. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2024-2032
  1. GCC Countries
  2. Egypt
  3. South Africa
  4. Northern Africa
  5. Rest of Middle East & Africa
3. Current Market Size (US$ Bn) Analysis and Forecast, By Diagnostic Test, 2024-2032
  1. Biomarker Test
    1. Prostate-Specific Antigen (PSA)
    2. Circulating Tumor Cells (CTC)
    3. Alpha-Fetoprotein (AFP)
    4. Cancer Antigen 125 (CA-125)
    5. HER2
    6. Other
  2. Imaging Technology
    1. Magnetic Resonance Imaging (MRI)
    2. Computed Tomography (CT)
    3. Positron Emission Tomography (PET)
    4. Mammography
    5. Others
  3. Endoscopy
  4. Colonoscopy
  5. Biopsy
  6. Others
4. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2024-2032
  1. Lung Cancer
  2. Breast Cancer
  3. Prostate Cancer
  4. Colorectal Cancer
  5. Melanoma Cancer
  6. Blood Cancer
  7. Ovarian Cancer
  8. Other
5. Current Market Size (US$ Bn) Analysis and Forecast, By End-use, 2024-2032
  1. Hospitals
  2. Diagnostic Laboratories
  3. Cancer Research Institutes
  4. Ambulatory Surgical Centers
6. Market Attractiveness Analysis
Competition Landscape
1. Market Share Analysis, 2024
2. Market Structure
  1. Competition Intensity Mapping by Market
  2. Competition Dashboard
3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
  1. F. Hoffmann-La Roche Ltd
    1. Overview
    2. Segments and Sources
    3. Key Financials
    4. Market Developments
    5. Market Strategy
  2. Thermo Fisher Scientific Inc.
  3. Abbott Laboratories
  4. Illumina Inc.
  5. bioMérieux SA
  6. Qiagen
  7. Siemens Healthineers
  8. GE Healthcare
  9. Hologic Inc.
  10. Agilent Technologies Inc.
  11. Becton, Dickinson and Company (BD)
  12. Myriad Genetics Inc.
  13. AstraZeneca
  14. Regeneron
  15. Novartis
  16. BIO-RAD LABORATORIES
  17. CANCER DIAGNOSTICS INC.
  18. QUIDEL CORPORATION
  19. Koninklijke Philips N.V. (Philips)
  20. Others
Appendix
1. Research Methodology
2. Research Assumptions
3. Acronyms and Abbreviations